DRIO Insider Trading

Insider Ownership Percentage: 10.90%
Insider Buying (Last 12 Months): $16,500.00
Insider Selling (Last 12 Months): $0.00

DarioHealth Insider Trading History Chart

This chart shows the insider buying and selling history at DarioHealth by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$10k$0$10kTotal Insider BuyingTotal Insider Selling

DarioHealth Share Price & Price History

Current Price: $0.62
Price Change: Price Decrease of -0.0328 (-5.00%)
As of 03/28/2025 05:00 PM ET

This chart shows the closing price history over time for DRIO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$0.62Closing price on 03/29/25:

DarioHealth Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for DarioHealth (NASDAQ:DRIO)

33.39% of DarioHealth stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at DRIO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$26kbought$72ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$1M$0$1MTotal InflowsTotal Outflows
DarioHealth logo
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Read More on DarioHealth

Today's Range

Now: $0.62
Low: $0.60
High: $0.66

50 Day Range

MA: $0.67
Low: $0.60
High: $0.75

52 Week Range

Now: $0.62
Low: $0.56
High: $1.93

Volume

192,692 shs

Average Volume

265,554 shs

Market Capitalization

$25.90 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.42

Who are the company insiders with the largest holdings of DarioHealth?

DarioHealth's top insider shareholders include:
  1. Erez Raphael (CEO)
  2. Steven Charles Nelson (Insider)
Learn More about top insider investors at DarioHealth.

Who are the major institutional investors of DarioHealth?

DarioHealth's top institutional shareholders include:
  1. Nantahala Capital Management LLC — 7.17%
  2. DLK Investment Management LLC — 0.42%
  3. LPL Financial LLC — 0.34%
  4. Citadel Advisors LLC — 0.00%
  5. Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of DarioHealth stock.

Which institutional investors are selling DarioHealth stock?

In the previous quarter, DRIO stock was sold by these institutional investors:
  1. Nantahala Capital Management LLC
  2. LPL Financial LLC
  3. Citadel Advisors LLC

Which institutional investors are buying DarioHealth stock?

During the last quarter, DRIO stock was purchased by institutional investors including:
  1. DLK Investment Management LLC
During the last year, these company insiders have bought DarioHealth stock:
  1. Erez Raphael (CEO)
  2. Steven Charles Nelson (Insider)
Learn More investors buying DarioHealth stock.